Key result
Early valve surgery for S. aureus PVE remains a case-by-case decision despite high mortality.
Why the study?
Does early valve surgery improve outcomes in patients with Staphylococcus aureus prosthetic valve infectious endocarditis?
Does early valve surgery improve outcomes in patients with Staphylococcus aureus prosthetic valve infectious endocarditis?
The optimal timing of valve surgery in Staphylococcus aureus prosthetic valve endocarditis remains individualized.
Staphylococcus aureus prosthetic valve infectious endocarditis (SA-PVIE) has a mortality rate of 40% to 80%. Several reports have suggested reduced
No takes yet. Share an insight, caveat, or question.
Neil M. Ampel (2015) studied this question. Early valve surgery for Staphylococcus aureus prosthetic valve endocarditis remains a case-by-case decision despite the condition's 40% to 80% mortality rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: